Brief: CStone Pharmaceuticals Says CEO Purchased 3.3 Million Of Co's Shares In Open Market In Six Months
29/04/2024 07:07
April 29 (Reuters) - CStone Pharmaceuticals 2616.HK :
* CEO PURCHASED 3.3 MILLION OF CO'S SHARES IN OPEN MARKET IN
SIX
MONTHS
* SINCE AUG 2022, CEO PURCHASED TOTAL OF 7.5 MILLION SHARES
IN
OPEN MARKET WITH PRICE RANGE OF HKD0.82 TO HKD4.60
Further company coverage: 2616.HK
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026